Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Andrés Gagete Mateos
Introduction
Andrés Gagete Mateos is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have potential therapeutic applications. With a total of 2 patents, his work focuses on inhibiting specific interactions that can lead to various medical complications.
Latest Patents
Andrés Gagete Mateos holds two recent patents that showcase his innovative approach to medical treatments. The first patent, titled "Chromene derivatives substituted by alkoxide as inhibitors of the TCR-Nck interaction," describes a group of compounds that contain a chromene nucleus. These compounds have the capacity to inhibit the proliferation of lymphocytes mediated by the Nck interaction with TCR. This invention is particularly relevant for treating diseases or conditions where this interaction can trigger complications, such as transplant rejection reactions, immune or autoimmune diseases, inflammatory diseases, or proliferative diseases. The second patent, "Chromene derivatives as inhibitors of TCR-Nck interaction," similarly focuses on compounds that inhibit lymphocyte proliferation mediated by the TCR interaction with Nck, emphasizing their potential use in treating related medical conditions.
Career Highlights
Throughout his career, Andrés has worked with various companies, including Artex Biopharma Inc. and Artax Biopharma Inc. His experience in these organizations has contributed to his expertise in biopharmaceutical innovations.
Collaborations
Andrés has collaborated with notable professionals in his field, including Julio Castro Palomino and Luc Marti Clauzel. These collaborations have likely enriched his research and development efforts.
Conclusion
Andrés Gagete Mateos is a distinguished inventor whose work in developing chromene derivatives has the potential to impact the treatment of various diseases significantly. His contributions to biochemistry and collaboration with other professionals highlight his commitment to advancing medical science.